# FDA 483 - BSP Pharmaceuticals SpA - February 29, 2024

Source: https://www.globalkeysolutions.net/records/483/bsp-pharmaceuticals-spa/58fbfc2c-ad6a-42b3-9087-1c14bd326f71

> FDA 483 for BSP Pharmaceuticals SpA on February 29, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BSP Pharmaceuticals SpA
- Inspection Date: 2024-02-29
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/bsp-pharmaceuticals-spa/80b28de2-cba0-4cb0-a7a6-f9c3b8074268)
- [483 - 2022-03-23](https://www.globalkeysolutions.net/records/483/bsp-pharmaceuticals-spa/68fa82b3-986f-4e5c-8ec1-dd7c474a41b0)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/bsp-pharmaceuticals-spa/6d9334e4-355f-4e21-ad72-92357fb9a296)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/michael-r-shanks/dd24952b-4309-451e-afe8-f68892cd7bac)
- [Deborah H. Schmiel](https://www.globalkeysolutions.net/people/deborah-h-schmiel/facfc308-52af-4353-902a-0d45d5d88020)

Company: https://www.globalkeysolutions.net/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd